Search results
Results from the WOW.Com Content Network
In 1914, New York first began to restrict cannabis by requiring a prescription to obtain the drug. In an amendment to the Boylan Bill, they added "Cannabis indica, which is the Indian hemp from which the East Indian drug called hashish is manufactured," to the city's list of restricted drugs.
Pages in category "Controlled substances in New York (state)" The following 4 pages are in this category, out of 4 total. This list may not reflect recent changes. A.
The adoption of the Rockefeller drug laws gave New York State the distinction of having the most severe laws of this kind in the entire United States—an approach soon imitated by the state of Michigan, which, in 1978, enacted a "650-Lifer Law", which called for life imprisonment, without the possibility of parole for the sale, manufacture, or ...
The drug or other substance has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug or other substance under medical supervision. The complete list of Schedule I substances is as follows. [1] The Administrative Controlled Substances Code Number for each substance is included.
At the federal level, cannabis remains a prohibited substance by way of the Controlled Substances Act (CSA) of 1970. Under the CSA, the Drug Enforcement Administration (DEA) classifies cannabis as a Schedule I drug, determined to have a high potential for abuse and no accepted medical use – thereby prohibiting its use for any purpose.
Dr. Herbert Kleber, a professor of psychiatry at Columbia University and director of the New York State Psychiatric Institute’s Division on Substance Abuse, argues that the robust black market is a sign that the benefit of the medication outweighs the risk. “There is no medication without risk. People die every year from aspirin.
For substance quantities of up to 100g, these companies do not require an import or export license”. In addition, import or export authorization is not required in case of controlled substances for analytical purpose in concentrations up to 1 mg/ml. (Art 23, Abs. 2b, BetmKV) [5]
Officials at the state Department of Juvenile Justice did not respond to questions about YSI. A department spokeswoman, Meghan Speakes Collins, pointed to overall improvements the state has made in its contract monitoring process, such as conducting more interviews with randomly selected youth to get a better understanding of conditions and analyzing problematic trends such as high staff turnover.